Tiny nanoparticles are at the forefront of materials science—with special properties that make them great at absorbing light in solar panels, cleaning wastewater, and delivering drugs precisely.
Some nanoparticles take the form of sheets or fibers. But nanomaterials all have one thing in common—their structure contains components with dimensions on the nanometer scale. That’s more than 10,000 times smaller than the width of a human hair. Research shows that nanomaterials often perform better than the same materials made on a larger scale. They have huge potential, but currently their manufacture can result in harmful environmental effects due to the use or production of hazardous chemicals.
I’m one of many researchers studying how to create, manipulate and apply these materials sustainably to develop new technologies and improve existing ones. This offers advantages across many applications, including aerospace, solar panels and electronics.
Silica nanomaterial is already all around you, but you probably don’t even realize it. Silica (SiO2), a compound that contains both silicon and oxygen, is commonly found in rocks. It is one of the most mass produced nanomaterials worldwide, with an expected market of US$5 trillion (£3.8 trillion) by 2025.
It’s used to make things you encounter every day, from improving the strength of concrete to improving the durability of rubber tires, plus it enhances the cleaning properties and consistency of toothpaste. Silica nanomaterial could have exciting high-value applications, like medicines and wastewater treatment.
While silica products might be great, the way they are made is often not great for the environment, or even economically feasible. Manufacturing is key to overall product sustainability, but it’s often invisible to consumers. As such, it’s an aspect that most people consider far less than, for example, whether something will be recycled.
Making silica often requires energy-intensive processes, or makes nasty waste products that are difficult to safely dispose of. Trying to reduce the environmental footprint of existing processes is not enough. Developing new production methods is paramount to ensuring that new technologies, such as more advanced solar panels, can both help society and have less impact on the environment than traditional manufacturing.
I am part of the Green Nanomaterials Research Group at the University of Sheffield, where my colleagues and I are working hard to develop sustainable, scalable and economical routes to functional nanostructured materials. We address aspects from discovery to manufacturing, applications and commercialization, considering the performance, scalability, environment and cost.
A greener approach to chemistry
We aim to make better nanomaterials for important applications, while considering the environmental impact at every stage of a nanomaterial’s life, from raw materials through to the use and disposal of a product and any by-products. This approach is known as “green chemistry,” a concept developed in 1998 that has been used to develop strategies for greener routes to nanomaterials.
Silica nanomaterial suits this green chemistry approach because it is already made in nature by plants and sponges as structural support. What better teacher for green chemistry than to learn from nature itself? My research group created bio-inspired silica, a product that can be made at room temperature, and in the mild conditions under which silica is made naturally in biology.
Now, colleagues in my research group are scaling up bio-inspired silica production, exploring its use in different applications and making different nanomaterials. Meanwhile, I’m exploring how changing the conditions under which we make silica can improve the properties, like surface area, that make it function better.
There’s huge scope for green nanomaterials to advance essential technologies, and if green silica could be scaled up, the potential for substantial change to drug delivery and renewables is vast.
Provided by The Conversation
News
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]















